Designed specifically for the Dimension EXL Integrated Chemistry System with LOCI Module, the SARS-CoV-2 IgG (CV2G) assay kit enables precise detection of IgG antibodies against SARS-CoV-2, aiding in the assessment of immune response to COVID-19.
Authorized for emergency use by the FDA, ensuring compliance with current regulatory standards for COVID-19 testing solutions.
Applicable for laboratories certified under CLIA to perform moderate or high complexity tests, broadening its availability to a wide range of clinical settings.
Includes 480 tests per kit, offering extensive testing capacity for healthcare facilities dealing with high testing demands.
Requires refrigeration for storage, maintaining the integrity and effectiveness of the reagents for reliable results.
